Literature DB >> 10657607

Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation.

O T Chan1, M J Shlomchik.   

Abstract

Spontaneous CD8+ T cell activation in MRL-Faslpr mice is B cell dependent. It is unclear whether this B-dependent activation is mediated by direct Ag presentation via MHC class I proteins (i.e., cross-presentation) or whether activation occurs by an indirect mechanism, e.g., via effects on CD4+ cells. To determine how CD8+ T cell activation is promoted by B cells, we created mixed bone marrow chimeras where direct MHC class I Ag presentation by B cells was abrogated while other leukocyte compartments could express MHC class I. Surprisingly, despite the absence of B cell class I-restricted Ag presentation, CD8+ T cell activation was intact in the chimeric mice. Therefore, the spontaneous B cell-dependent CD8+ T cell activation that occurs in systemic autoimmunity is not due to direct presentation by B cells to CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657607     DOI: 10.4049/jimmunol.164.4.1658

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

Review 2.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

3.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

4.  B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells.

Authors:  Ruan Zhang; Peter T Sage; Kelsey Finn; Alexandria Huynh; Bruce R Blazar; Francesco Marangoni; Thorsten R Mempel; Arlene H Sharpe; Laurence A Turka
Journal:  J Immunol       Date:  2017-11-01       Impact factor: 5.422

Review 5.  B cell depletion therapy in systemic lupus erythematosus.

Authors:  Jennifer Anolik; Iñaki Sanz; R John Looney
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 6.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

7.  B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice.

Authors:  Yongmei Li; Fangqi Chen; Mary Putt; Yumee K Koo; Michael Madaio; John C Cambier; Philip L Cohen; Robert A Eisenberg
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey S Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

9.  B Cell in Autoimmune Diseases.

Authors:  Christiane S Hampe
Journal:  Scientifica (Cairo)       Date:  2012

Review 10.  Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Authors:  Simanta Pathak; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.